Exploring Alternative Cancer Treatments: From Ivermectin to Nanorobots!
In the quest to combat cancer, a disease that remains one of the leading causes of death worldwide, the medical community continually seeks innovative and alternative treatments. Here’s an overview of several unconventional approaches currently under investigation or discussion: Ivermectin and FenbendazoleIvermectin, traditionally an antiparasitic drug, has been studied for its potential antitumor effects. Research has shown that it can inhibit cancer cell proliferation, induce apoptosis, and modulate pathways like EGFR/ERK/Akt/NF-κB, potentially reversing drug resistance in cancer cells. Similarly, fenbendazole, another antiparasitic, has garnered attention for its potential in cancer treatment. There are anecdotal reports and some preclinical studies suggesting it might inhibit cancer cell growth. Both drugs have been part of protocols like the Joe Tippens Protocol, where they are combined with other supplements and dietary changes, showing some promise in case studies. Tata Institute’s Breakthrough in Cancer Drug DevelopmentThe Tata Institute has been at the forefront of cancer research, developing innovative drugs. One notable breakthrough involves targeting cancer cell metabolism with drugs that can selectively kill cancer cells while sparing healthy ones. Although specific details on the drug are sparse due to ongoing research, this approach aims at disrupting cancer’s energy supply, a novel strategy in cancer therapy. Small Extracellular Vesicles (sEVs)Small extracellular vesicles are nanometer-sized vesicles released by cells that can transfer molecular information between cells, including from cancer cells to healthy ones, influencing tumor progression. Research into sEVs focuses on their potential as biomarkers for early cancer detection and as carriers for therapeutic agents. By loading…
Romanian fossils show hominins in Europe 500,000 years earlier than thought
by Justin Jackson , Phys.org Research led by the Department of Sociology & Anthropology at Ohio University has found evidence of hominin activity at a Romanian fossil site dating to at least 1.95 million years ago. This discovery pushes back the known date of European hominins by half a million years and establishes Grăunceanu as the oldest confirmed European evidence of hominin activity. Grăunceanu, part of the Tetoiu Formation in Romania, lies within a Late Villafranchian biochronological zone (2.2–1.9 Ma) and has yielded a diverse faunal assemblage indicative of a forest-steppe environment. The timing of the earliest hominin dispersals into Eurasia has been elusive. Fossil evidence from Dmanisi, Georgia (~1.85–1.77 million years ago) represents the earliest indisputable hominin presence outside Africa. Isolated sites in Europe and Asia with lithics and bone modifications suggest earlier, intermittent hominin activity. Until now, no European site had reliably demonstrated hominin activity predating ~1.4 million years ago with robust age determinations. In the study, “Hominin presence in Eurasia by at least 1.95 million years ago,” published in Nature Communications, researchers analyzed faunal remains from Grăunceanu, a site in the Olteţ River Valley of Romania, identifying cut marks indicative of hominin butchery methods. A total of 4,524 specimens were examined for surface modifications such as weathering, root etching, and anthropogenic cut marks. Linear marks were analyzed macroscopically and quantitatively using 3D optical profilometry. Twenty bones exhibited anthropogenic surface modifications, including seven high-confidence cut-marked specimens. These marks were found on animal tibiae and mandibles, showing straight, transverse trajectories consistent with…
Chicago pastor cuts hair and lifts spirits with free services and support at the Grand Regency Supportive Living Facility!
“Free haircuts by Pastor Leonard Smith at the Grand Regency Supportive Living Facility!”
Deborah Tavares: NASA’s ‘Future Warfare’ and the Bilderbergers’ ‘Silent Weapons for Quiet Wars’
By Rhoda Wilson on September 17, 2024 • ( 24 Comments ) In 2013, Deborah Tavares, a prominent researcher and whistleblower, brought attention to a NASA document titled ‘Future Strategic Issues/Future Warfare [Circa 2025]’. The document, presented by Dennis Bushnell, Chief Scientist at NASA’s Langley Research Centre in July 2001, outlines the Illuminati’s plans for humanity’s supposed “failure” as a species. According to Tavares, the document reveals a plan to replace humanity, implying a depopulation agenda. The document’s focus on “future warfare” and “strategic issues” suggests a comprehensive plan for global control and manipulation. Tavares also referenced ‘Silent Weapons for Quiet Wars’, a 1954 Bilderberg policy paper, which ties into the NASA document. This earlier document outlines a strategy for controlling populations through subtle, psychological manipulation, rather than overt violence. In October 2023, Tavares uploaded her 2013 interview with Trevor Coppola onto her website ‘Stop the Crime’. You can watch the interview below, after which we have highlighted a few of the revelations she made. Future Strategic Issues/Future Warfare [Circa 2025] Tavares refers to Future Strategic Issues/Future Warfare [Circa 2025] as the “NASA war document that was found on the NASA website.” It can be read online HERE or HERE. In the event that these are moved or removed, we have included a copy below. The first page in the copy below is a summary of a “few examples of what is in the NASA document that are happening now’ prepared by Tavares and uploaded onto her website. We have also uploaded a copy of ‘Silent Weapons for Quiet Wars’ which Tavares also…
Alex Jones Responds To Mel Gibson Exposing Documented Cancer Cures Being Suppressed By Big Pharma
“All 3 of them had stage 4 Cancer”: There Is a “Cure” for Cancer, Mel Gibson and Joe Rogan Feel It’s Not Being Promoted Enough Mel Gibson and Joe Rogan discuss controversial cancer treatments while alleging how pharmaceuticals are suppressing these cures. Cancer has long been one of the most terrifying ailments in the history of humanity and an equally daunting challenge in modern medicine. And, despite billions of dollars being funded for research and treatment, medical experts have claimed to find rarely any solid cure for the disease. Amid such lack of progress, Mel Gibson joined Joe Rogan to ignite debate surrounding controversial cancer cures, during their recent podcast. Appearing on The Joe Rogan Experience, Mel Gibson claimed how three of his friends, diagnosed with stage four cancer, found their cure in treatments that remain fraught with controversy. Sparking curiosity among listeners, Gibson and Rogan stated how they believe the potential cure for cancer is being suppressed by the medical establishments, for whatever reason. Mel Gibson sparked curiosity with a controversial cure for cancer After previously appearing on Joe Rogan’s podcast in 2018 and reflecting on his father’s stem cell cure, Mel Gibson once again paid a visit to The Joe Rogan Experience, in 2025. Yet again speaking on a series of intriguing claims about unconventional medical treatments, the actor and director Gibson set social media ablaze with his stories. Speaking with the podcast host Joe Rogan on medical advancements and controversial treatments, Mel Gibson shared a story about three of his friends,…
Game-Changing Dual Cancer Therapy Completely Eradicates Tumors Without Harsh Side Effects
Dual Combining phototherapy with chemotherapy may provide a more powerful approach to combat aggressive tumors effectively. Patients with late-stage cancer often have to endure multiple rounds of different types of treatment, which can cause unwanted side effects and may not always help. In hopes of expanding the treatment options for those patients, MIT researchers have designed tiny particles that can be implanted at a tumor site, where they deliver two types of therapy: heat and chemotherapy. This approach could avoid the side effects that often occur when chemotherapy is given intravenously, and the synergistic effect of the two therapies may extend the patient’s lifespan longer than giving one treatment at a time. In a study of mice, the researchers showed that this therapy completely eliminated tumors in most of the animals and significantly prolonged their survival. “One of the examples where this particular technology could be useful is trying to control the growth of really fast-growing tumors,” says Ana Jaklenec, a principal investigator at MIT’s Koch Institute for Integrative Cancer Research. “The goal would be to gain some control over these tumors for patients that don’t really have a lot of options, and this could either prolong their life or at least allow them to have a better quality of life during this period.” Jaklenec is one of the senior authors of the new study, along with Angela Belcher, the James Mason Crafts Professor of Biological Engineering and Materials Science and Engineering and a member of the Koch Institute, and Robert Langer,…
Humans originated in Europe, not Africa, according to fossil discovery
This find challenges the long-held belief that human ancestors evolved solely in Africa, suggesting instead that Europe played a significant role in our evolutionary history. The fossil, uncovered at the Çorakyerler site with support from Türkiye’s Ministry of Culture and Tourism, reveals that Mediterranean fossil apes were more diverse than previously thought. These apes are part of the earliest known group of hominins, which includes not only African apes like chimpanzees, bonobos, and gorillas but also humans and their fossil ancestors. Out of Africa? Maybe not This discovery adds weight to the theory that the ancestors of African apes and humans may have evolved in Europe before migrating to Africa between nine and seven million years ago. Professor David Begun from the University of Toronto and Professor Ayla Sevim Erol from Ankara University led the international team of researchers who conducted the study. “Our findings further suggest that hominines not only evolved in western and central Europe but spent over five million years evolving there and spreading to the eastern Mediterranean before eventually dispersing into Africa, probably as a consequence of changing environments and diminishing forests,” explained Professor Begun. “The members of this radiation to which Anadoluvius turkae belongs are currently only identified in Europe and Anatolia.” Partial skull of Anadoluvius turkae The conclusion drawn from the study is based on the analysis of a well-preserved partial cranium discovered in 2015. This fossil includes most of the facial structure and the front part of the braincase, providing valuable insights into the ape’s anatomy. “The completeness of the fossil…